Stoke Therapeutics Inc buy Credit Suisse Group AG
Start price
08.08.23
/
50%
€4.88
Target price
08.08.24
€21.00
Performance (%)
111.07%
Price
29.04.24
€11.10
Summary
This prediction is currently active. The BUY prediction by Credit_Suisse_Group_ for Stoke Therapeutics Inc has seen massive gains of 111.07%. This prediction currently runs until 08.08.24. The prediction end date can be changed by Credit_Suisse_Group_ at any time. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 4.717% | 4.717% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $23.00 price target on the stock.
Ratings data for STOK provided by MarketBeat